Is it easy to use dabrafenib combined with trametinib?
Clinical trials have shown that the combination of dabrafenib and trametinib is more effective in treating advanced melanoma than either drug alone. Side effects from combination medications are also less severe than those from either drug alone. The combination of dabrafenib and trametinib blocks the signaling pathways of abnormal BRAF molecules, which slows or stops uncontrolled cell growth.
The method of using dabrafenib and trametinib is relatively complex because it needs to be individualized according to the specific situation of the patient. Generally speaking, the use of these two drugs requires the guidance and supervision of a doctor, who will conduct a detailed evaluation and examination to determine the best dosage and regimen before starting treatment. According to both clinical guidelines, the recommended dose of dabrafenib is 150 mg in 50 or 75 mg capsules twice daily. The recommended dose of trametinib is 2 mg once daily in 0.5, 1, or 2 mg tablets. Depending on the patient's response to treatment, the doctor may adjust the dose of the drug. Patients typically continue taking these medications for a period of time until their melanoma worsens or they experience unacceptable side effects.
The original drug of dabrafenib is relatively expensive and has been covered by medical insurance since it was launched in China. Currently only eligible patients are reimbursed. The price of each box of 50mg*120 capsules may be around around 10,000. The Turkish version of the original drug Dabrafenib sold overseas, Specifications 75mg*120 capsules, may cost around 10,000 per box (the price may fluctuate due to exchange rates). There are also relatively cheap generics of dabrafenib sold overseas, and their pharmaceutical ingredients are basically the same as those of the original drugs sold domestically and abroad. For example, Specifications produced by Laos Pharmaceutical Factory The price of 75mg*120 tablets per box may be more than 4,000 yuan (the price may fluctuate due to exchange rates).
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)